General Information of Drug Transporter (DT)
DT ID DTD0348 Transporter Info
Gene Name SLC39A7
Transporter Name Zinc transporter SLC39A7
Gene ID
7922
UniProt ID
Q92504
Post-Translational Modification of This DT
Overview of SLC39A7 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Methylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A7 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

310

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC39A7 Lysine 310 has the potential to affect its expression or activity.

Methylation

  Histidine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Impairing the function of SLC39A7 [2]

Role of PTM

Protein Activity Modulation

Modified Residue

Histidine

Related Enzyme

Protein-L-histidine N-pros-methyltransferase (METTL9)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC39A7 Histidine have been reported to impaire its transport function.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

146

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 146 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

160

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 160 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

162

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 162 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC39A7 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC39A7 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

275

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 275 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC39A7 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

276

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 276 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC39A7 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

293

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Serine 293 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Threonine 133 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

142

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Threonine 142 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC39A7 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

283

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Threonine 283 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC39A7 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

294

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Threonine 294 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A7 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

137

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A7 Tyrosine 137 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A7 [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

310

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A7 Lysine 310 has the potential to affect its expression or activity.
References
1 Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
2 The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat Commun. 2021 Feb 9;12(1):891.
3 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
4 Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia. Sci Rep. 2015 Sep 2;5:13660.
5 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
6 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
7 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
8 Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics. Front Cell Dev Biol. 2017 Nov 22;5:97.
9 Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
10 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
11 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.